For the test against the new virus Brilacidin required people with a needle direct in a vein to administer the drug. It is how it was tested with success for MRSA. People with only mild virus sickness do not have a needle in a vein. People with moderate virus sickness maybe have a needle or maybe not.
There was no USA FDA conspiracy against Brilacidin and Ipix.
I did hope the anti-inflammation action of Brilacidin could help those who were super sick.
The anti-viral story with Brilacidin is in only the first chapter.
Market Data 
Markets 
AI
